Security key
70261F202
Pasithea Therapeutics Corp. - Common Stock (KTTA)
CUSIP: 70261F202
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 29,996
- Total 13F value
- $151,569
- Share change
- -59
- SEC-reported price per share
- $5.06
- Number of holders
- 7
- Value change
- -$300
- Number of buys
- 3
- Number of sells
- 2
- Shares outstanding
- 33,664,655
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
7
Top holders
7
KTTA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Pasithea Therapeutics Corp. SEC filings
Pasithea Therapeutics Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 70261F202
Recent filing periods:
Ownership snapshot
Top reported holders of KTTA - Pasithea Therapeutics Corp. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ADAR1 Capital Management,...
Disclosed value leader
PD Joint Holdings, LLC Se...
Comparable rows
6/15
Latest evidence
31 Mar 2024
13F
3/4/5
Lead comparable stake: 0.08%
9 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ADAR1 Capital Management, LLC leads the comparable SEC ownership view at 0.08%.
6 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ADAR1 Capital Management, LLC's linked filing trail.
Comparable ownership
Top 5
ADAR1 Capital Management, LLC
0.08%
Tower Research Capital LLC (TRC)
0%
UBS Group AG
0%
ROYAL BANK OF CANADA
0%
JPMORGAN CHASE & CO
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC |
13F
Company
|
0.08%
|
$200,804
27,696 shares
|
— | 31 Mar 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0%
|
$9,751
1,345 shares
|
— | 31 Mar 2024 |
| UBS Group AG |
13F
Company
|
0%
|
$4,408
608 shares
|
— | 31 Mar 2024 |
| ROYAL BANK OF CANADA |
13F
Company
|
0%
|
$2,000
250 shares
|
— | 31 Mar 2024 |
| JPMORGAN CHASE & CO |
13F
Company
|
0%
|
$1,095
150 shares
|
— | 31 Mar 2024 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
0%
|
$44
6 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
29,996
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
6
Q2 2024 holders
7
Holder diff
1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend